CRSP
CRISPR Therapeutics·NASDAQ
--
--(--)
--
--(--)
CRSP fundamentals
CRISPR Therapeutics (CRSP) released its earnings on Nov 10, 2025: revenue was 889.00K (YoY +47.67%), missed estimates; EPS was -1.17 (YoY -15.84%), beat estimates.
Revenue / YoY
889.00K
+47.67%
EPS / YoY
-1.17
-15.84%
Report date
Nov 10, 2025
Earnings
EPS
Revenue
Revenue & Expenses
CRSP has released its 2025 Q4 earnings report, with revenue of 864.00K, reflecting a YoY change of -97.58%, and net profit of -130.61M, showing a YoY change of -250.07%. The Sankey diagram below clearly presents CRSP's revenue sources and cost distribution.
Key Indicators
CRISPR Therapeutics (CRSP) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
CRISPR Therapeutics (CRSP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
CRISPR Therapeutics (CRSP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
CRISPR Therapeutics (CRSP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does CRISPR Therapeutics (CRSP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track CRISPR Therapeutics (CRSP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does CRISPR Therapeutics do and what are its main business segments?What guidance did CRISPR Therapeutics's management provide for the next earnings period?What were the key takeaways from CRISPR Therapeutics's earnings call?What is the market's earnings forecast for CRISPR Therapeutics next quarter?Did CRISPR Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for CRISPR Therapeutics year over year?What is CRISPR Therapeutics's latest dividend and current dividend yield?What is CRISPR Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
